In addition, diabetes induced upregulation of RAGE, ERK, and NF-κB; however, oral administration of glycyrrhizin, a specific inhibitor of HMGB-1, attenuated NF-κB activation. The gene discussed is NFKB1; the disease is diabetes mellitus.